BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 17442474)

  • 1. Norcantharidin preferentially induces apoptosis in human leukemic Jurkat cells without affecting viability of normal blood mononuclear cells.
    Liao HF; Su SL; Chen YJ; Chou CH; Kuo CD
    Food Chem Toxicol; 2007 Sep; 45(9):1678-87. PubMed ID: 17442474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norcantharidin induces apoptosis in HeLa cells through caspase, MAPK, and mitochondrial pathways.
    An WW; Gong XF; Wang MW; Tashiro S; Onodera S; Ikejima T
    Acta Pharmacol Sin; 2004 Nov; 25(11):1502-8. PubMed ID: 15525474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells.
    Chen YN; Chen JC; Yin SC; Wang GS; Tsauer W; Hsu SF; Hsu SL
    Int J Cancer; 2002 Jul; 100(2):158-65. PubMed ID: 12115564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norcantharidin induces anoikis through Jun-N-terminal kinase activation in CT26 colorectal cancer cells.
    Chen YJ; Kuo CD; Tsai YM; Yu CC; Wang GS; Liao HF
    Anticancer Drugs; 2008 Jan; 19(1):55-64. PubMed ID: 18043130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norcantharidin triggers cell death and DNA damage through S-phase arrest and ROS-modulated apoptotic pathways in TSGH 8301 human urinary bladder carcinoma cells.
    Yu CC; Ko FY; Yu CS; Lin CC; Huang YP; Yang JS; Lin JP; Chung JG
    Int J Oncol; 2012 Sep; 41(3):1050-60. PubMed ID: 22684608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norcantharidin-induced apoptosis in oral cancer cells is associated with an increase of proapoptotic to antiapoptotic protein ratio.
    Kok SH; Cheng SJ; Hong CY; Lee JJ; Lin SK; Kuo YS; Chiang CP; Kuo MY
    Cancer Lett; 2005 Jan; 217(1):43-52. PubMed ID: 15596295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norcantharidin induces cell cycle arrest and inhibits progression of human leukemic Jurkat T cells through mitogen-activated protein kinase-mediated regulation of interleukin-2 production.
    Liao HF; Chen YJ; Chou CH; Wang FW; Kuo CD
    Toxicol In Vitro; 2011 Feb; 25(1):206-12. PubMed ID: 21075198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of mitochondrial pathway in NCTD-induced cytotoxicity in human hepG2 cells.
    Chang C; Zhu YQ; Mei JJ; Liu SQ; Luo J
    J Exp Clin Cancer Res; 2010 Nov; 29(1):145. PubMed ID: 21059274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norcantharidin-induced Apoptosis of AGS Human Gastric Cancer Cells Through Reactive Oxygen Species Production, and Caspase- and Mitochondria-dependent Signaling Pathways.
    Zheng LC; Yang MD; Kuo CL; Lin CH; Fan MJ; Chou YC; Lu HF; Huang WW; Peng SF; Chung JG
    Anticancer Res; 2016 Nov; 36(11):6031-6042. PubMed ID: 27793930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro.
    Fan YZ; Fu JY; Zhao ZM; Chen CQ
    Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):72-80. PubMed ID: 17287171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Farnesyloxy-norcantharimide inhibits progression of human leukemic Jurkat T cells through regulation of mitogen-activated protein kinase and interleukin-2 production.
    Chang MC; Wu JY; Liao HF; Chen YJ; Kuo CD
    Anticancer Drugs; 2015 Nov; 26(10):1034-42. PubMed ID: 26288134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norcantharidin reduced cyclins and cytokines production in human peripheral blood mononuclear cells.
    Chen YC; Chang SC; Wu MH; Chuang KA; Wu JY; Tsai WJ; Kuo YC
    Life Sci; 2009 Feb; 84(7-8):218-26. PubMed ID: 19100750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitory effect of norcantharidin combined with evodiamine on the growth of human hepatic carcinoma cell line HepG2 in vitro].
    Liu Y; Zahng J; You Z; Liao H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):824-8. PubMed ID: 25108435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caspase-dependent molecular mechanisms of anti-human DR5 monoclonal antibody mDRA-6 inducing apoptosis of human leukemia Jurkat cells.
    Du YW; Liu GC; Wang J; Zhao YP; Li SL; Chen JG; Jiang Q; Cai J; Ma YF
    Ai Zheng; 2009 Feb; 28(2):112-6. PubMed ID: 19550122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular mechanism of norcantharidin inducing apoptosis in liver cancer cells].
    Li GQ; Zhang SJ; Lü JF; Wu Y; Li J; Zhang G; Yu JT
    Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(30):2145-8. PubMed ID: 21029633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norcantharidin Enhances High Concentrations of Fetal Bovine Serum-Induced Apoptosis in Human Mesangial Cells by Regulating the Mitogen-Activated Protein Kinase Signaling Pathway.
    Ye K; Wei QY; Long TX; He HG; Huang YF; Xiong LJ; Lan J; Huang YY; Gong ZF; Peng XM; Wu QX
    Kidney Blood Press Res; 2019; 44(6):1339-1351. PubMed ID: 31661692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Norcantharidin induces human melanoma A375-S2 cell apoptosis through mitochondrial and caspase pathways.
    An WW; Wang MW; Tashiro S; Onodera S; Ikejima T
    J Korean Med Sci; 2004 Aug; 19(4):560-6. PubMed ID: 15308848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norcantharidin inhibits growth of human gallbladder carcinoma xenografted tumors in nude mice by inducing apoptosis and blocking the cell cycle in vivo.
    Fan YZ; Zhao ZM; Fu JY; Chen CQ; Sun W
    Hepatobiliary Pancreat Dis Int; 2010 Aug; 9(4):414-22. PubMed ID: 20688607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Norcantharidin-induced apoptosis is via the extracellular signal-regulated kinase and c-Jun-NH2-terminal kinase signaling pathways in human hepatoma HepG2 cells.
    Chen YN; Cheng CC; Chen JC; Tsauer W; Hsu SL
    Br J Pharmacol; 2003 Oct; 140(3):461-70. PubMed ID: 12970086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of p38 MAPK Pathway to Norcantharidin-Induced Programmed Cell Death in Human Oral Squamous Cell Carcinoma.
    Ahn CH; Hong KO; Jin B; Lee W; Jung YC; Lee H; Shin JA; Cho SD; Hong SD
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31315217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.